ecancer

Sacituzumab govitecan combination shows promising activity in first line metastatic urothelial cancer

Dr Randy Sweis - University of Chicago, Chicago, USA

24 Oct 2026

Equitable HPV vaccination for all

Peter Baker - Global Action on Men’s Health

9 Oct 2026

Bladder cancer updates from the first half of 2026

Prof Alison Birtle, Dr Ignacio Duran, Dr Laura Mertens, Prof Morgan Rouprêt and Dr Patrizia Giannatempo

31 Jul 2026

The impact of disease burden: Understanding patient priorities in aRCC

Prof Thomas Powles and Dena Battle

20 Jul 2026

Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC

Dr Rahul Aggarwal - University of California, San Francisco, USA

26 Jun 2026

Highlights from APCCC 2026

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina

24 Jun 2026

ASCO 2026: Updates in bladder cancer

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina

24 Jun 2026

ASCO 2026: Updates in renal cancer

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina

23 Jun 2026

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina

22 Jun 2026

Understanding patient expectations and clinicians' goals in favourable risk aRCC patients

Prof Daniele Santini and Dr Yann Alexandre Vano

15 Jun 2026

Talazoparib plus enzalutamide improves radiographic progression-free survival in HRR-altered mCSPC

Dr Neeraj Agarwal - University of Utah, Salt Lake City, USA

9 Jun 2026

ASCO 2026: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

1 Jun 2026

More from ecancer